Suppr超能文献

粪便免疫化学检测(FIT)与光学结肠镜检查的比较的检测特性。

Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.

机构信息

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242 Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242 Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242.

出版信息

J Med Screen. 2014 Sep;21(3):133-43. doi: 10.1177/0969141314541109. Epub 2014 Jun 23.

Abstract

BACKGROUND

Faecal occult blood tests are often the initial test in population-based screening. We aimed to: 1) compare the results of single sample faecal immunochemical tests (FITs) with colonoscopy, and 2) calculate the sensitivity for proximal vs. distal adenomatous polyps or cancer.

METHODS

Individuals scheduled for a colonoscopy were invited to complete a FIT prior to their colonoscopy preparation. FIT results were classified as positive, negative, or invalid. Colonoscopy reports were reviewed and abstracted. Because of product issues, four different FIT manufacturers were used. The test characteristics for each FIT manufacturer were calculated for advanced adenomatous polyps or cancer according to broad reason for colonoscopy (screening or surveillance/diagnostic).

RESULTS

Of those invited, 1,026 individuals (43.9%) completed their colonoscopy and had a valid FIT result. The overall sensitivity of the FITs (95% confidence intervals) was 0.18 (0.10 to 0.28) and specificity was 0.90 (0.87 to 0.91) for advanced adenomas or cancer. The sensitivity for distal lesions was 0.23 (0.11 to 0.38) and for proximal lesions was 0.09 (0.02 to 0.25). The odds ratio of an individual with a distal advanced adenoma or cancer testing positive was 2.68 (1.20 to 5.99). The two individuals with colorectal cancer tested negative, as did one individual with high-grade dysplasia.

CONCLUSIONS

The sensitivity of a single-sample FIT for advanced adenomas or cancer was low. Individuals with distal adenomas had a higher odds of testing positive than those with proximal lesions or no lesions.

摘要

背景

粪便潜血试验常用于人群筛查的初始检测。我们的目的是:1)比较单次粪便免疫化学检测(FIT)与结肠镜检查的结果,2)计算近端与远端腺瘤性息肉或癌症的敏感性。

方法

预约结肠镜检查的个体被邀请在结肠镜检查准备前完成 FIT。FIT 结果分为阳性、阴性或无效。审查并摘录结肠镜检查报告。由于产品问题,使用了四个不同的 FIT 制造商。根据结肠镜检查的广泛原因(筛查或监测/诊断),为每个 FIT 制造商计算了用于高级腺瘤性息肉或癌症的测试特征。

结果

受邀者中有 1026 人(43.9%)完成了结肠镜检查并获得了有效的 FIT 结果。FIT 的总体敏感性(95%置信区间)为 0.18(0.10 至 0.28),特异性为 0.90(0.87 至 0.91),用于高级腺瘤或癌症。远端病变的敏感性为 0.23(0.11 至 0.38),近端病变的敏感性为 0.09(0.02 至 0.25)。远端高级腺瘤或癌症患者检测阳性的个体的优势比为 2.68(1.20 至 5.99)。两名结直肠癌患者检测结果为阴性,一名高级别异型增生患者也是如此。

结论

单次样本 FIT 对高级腺瘤或癌症的敏感性较低。远端腺瘤患者检测阳性的几率高于近端病变或无病变患者。

相似文献

引用本文的文献

8

本文引用的文献

2
Multitarget stool DNA testing for colorectal-cancer screening.多靶点粪便 DNA 检测用于结直肠癌筛查。
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
4
The "Iowa get screened" colon cancer screening program.爱荷华州结肠癌筛查项目“我要接受筛查”。
J Prim Care Community Health. 2010 Apr 1;1(1):43-9. doi: 10.1177/2150131909352191.
5
Evaluation of fecal immunochemical tests for colorectal cancer screening.用于结直肠癌筛查的粪便免疫化学检测评估
J Prim Care Community Health. 2013 Oct;4(4):245-50. doi: 10.1177/2150131913487561. Epub 2013 May 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验